Categories Cancer

‘Patchwork’ tumours prevalent across multiple cancer types | Crick

‘Patchwork’ tumours prevalent across multiple cancer types | Crick Cancer cells. Researchers at the Francis Crick Institute, as part of an international collaboration of scientists through the Pan-Cancer Analysis of Whole Genomes Consortium, have analysed the whole genomes of tumour samples from over 2,600 patients with different types of cancer. They identified a high prevalence […]

Read More
Categories Cancer

Cancer patients could be at risk if second doses delayed beyond three weeks, oncologists say

Cancer patients could be at risk if second doses delayed beyond three weeks, oncologists say TORONTO — Experts are ringing the alarm bell over the prevailing policy of delaying the second dose of the vaccine for up to four months, saying this strategy could leave cancer patients unprotected. Citing preliminary research from the U.K., the […]

Read More
Categories Multiple Myeloma

Cancer Screening Stopped by Pandemic: Repercussions to Come?

Cancer Screening Stopped by Pandemic: Repercussions to Come? Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Last year, cancer screening programs around the world ground to a halt as SARS-CoV-2 infection rates surged globally. The effect of this slowdown is now becoming clear. Thousands of cancer diagnoses are “missing,” […]

Read More
Categories Multiple Myeloma

FDA Approvals Roundup: Qelbree, Sarclisa, Tyvaso

FDA Approvals Roundup: Qelbree, Sarclisa, Tyvaso Posted 07 April 2021 | By Renee Matthews  A weekly update on new drug approvals and indications from the US Food and Drug Administration (FDA). New approvalsQelbree okayed as nonstimulant therapy option for children with ADHDSupernus’s Qelbree (viloxazine extended-release capsules) has been approved for the treatment of  attention deficit hyperactivity […]

Read More